Fisher & Paykel Healthcare Says Unauthorized Access Hit Files and Two Employee Email Accounts

Fisher & Paykel Healthcare said on October 21, 2026 that it was made aware of unauthorized and unlawful access to a subset of company files and two employee email accounts. The medical device maker said it has notified the relevant authorities, according to Reuters.

What Fisher & Paykel Healthcare Said Was Accessed

Some of the files accessed contained personally identifiable information, and the company is in the process of informing the people affected. "There is no evidence that the unlawful activity compromised the company's system that maintains patient data," the New Zealand company said.

Fisher & Paykel Healthcare makes devices to treat obstructive sleep apnea. The company said there has been no impact on its products, manufacturing operations or supply chain.

Fisher & Paykel Healthcare said it believes the incident is contained, with no evidence of ransomware or malware identified, and that it expects no material financial impact. New Zealand's National Cyber Security Centre did not immediately respond to a Reuters request for comment on the issue.

The disclosure came a day after government websites in Europe and elsewhere went offline, when the disclosure of critical flaws in a widely used programming language sent site operators worldwide scrambling to protect their systems.

Fisher & Paykel Healthcare's Solar and Product Record

Fisher & Paykel Healthcare partnered with Sunergise under a Power Purchase Agreement to install a 5.3 MW rooftop solar system at its Auckland campus with no upfront capital cost, according to akta.pro company records. The system covers roughly 70,000 m2 and uses 8,273 modules.

The company launched the F&P Airvo 3 next-generation high flow therapy system in 2025, with an integrated battery, high-pressure oxygen input, a 2-70 L/min flow range, real-time respiratory monitoring, a touchscreen interface and backward compatibility with Airvo 2 consumables. It also launched the F&P Evora Full full-face CPAP mask in 2025, featuring Dynamic Support Technology and VentiCool breathable headgear, extending the Evora line into the full-face OSA segment.

Fisher & Paykel Healthcare reported record operating revenue of NZ$2.02 billion for the financial year ended March 2025, a 16% increase from the prior year and the first time annual revenue exceeded NZ$2 billion. Net profit after tax rose 43% to NZ$377.2 million, and operating cash flow reached NZ$549 million.

Fisher & Paykel Healthcare's Recent Guidance and Solar Build

In August 2026, Fisher & Paykel Healthcare raised its full-year 2027 profit guidance to NZ$525-565 million and presented an upbeat forecast for the first half of the financial year, Investing.com reported.

Also in August 2026, JA Solar supplied and installed an 8,273-module photovoltaic system for Fisher & Paykel Healthcare in Auckland, establishing New Zealand's largest rooftop PV station, FinanzNachrichten.de reported. SolarQuarter reported that the 5.3 MWp rooftop solar project at a Fisher & Paykel Healthcare manufacturing facility in Auckland was developed by Sunergise.

In July 2026, Fisher & Paykel Healthcare was named among the finalists for the annual New Zealand CIO Innovation Awards 2026, recognized for contributions to technology and digital transformation, NZ Herald reported.

What Fisher & Paykel Healthcare Said Comes Next

Fisher & Paykel Healthcare said it is in the process of informing the people affected by the file access and has notified the relevant authorities.